OBJETIVO: O furoato de mometasona (FM) é um novo corticosteroide inalatório sintético potente. Internacionalmente, o FM é fornecido em um inalador de pó seco que permite sua administração em múltiplas doses.
Carlos Alberto de Castro Pereira +9 more
doaj +1 more source
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C. [PDF]
Ronchetti R +6 more
europepmc +1 more source
Effects of nigella sativa oil on allergic rhinitis: an experimental animal study. [PDF]
Gul R +6 more
europepmc +1 more source
Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis. [PDF]
Ow RA +9 more
europepmc +1 more source
Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy. [PDF]
Grounds MD, Lloyd EM.
europepmc +1 more source
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice. [PDF]
Ziemba M +8 more
europepmc +1 more source
Exposure-Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy. [PDF]
Li X +5 more
europepmc +1 more source
Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment. [PDF]
Liu X +6 more
europepmc +1 more source
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys. [PDF]
Dang UJ +6 more
europepmc +1 more source
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset. [PDF]
Damsker JM +12 more
europepmc +1 more source

